Hospital General De Tomelloso

At Hospital General De Tomelloso, the Servicio de Gastroenterología y Hepatología is involved in studies focused on Digestive System Diseases and Immune System Diseases, especially conditions marked by chronic inflammation of the esophagus and intestines. The research is aimed at improving treatment options and understanding how to better control symptoms and tissue inflammation.

• Eosinophilic esophagitis and related chronic inflammatory esophageal disorders
• Crohn's Disease and Ulcerative Colitis
• Testing new therapies to reduce inflammation and improve symptom relief

This area reflects a strong focus on gastrointestinal immune diseases, with trials designed to evaluate how well emerging treatments can help patients achieve better disease control and long-term comfort.

The site is also studying Nutritional and Metabolic Diseases and Physiological processes linked to liver health, with attention to Metabolic Dysfunction-Associated Steatohepatitis and Non-alcoholic steatohepatitis. These trials are exploring new ways to reduce liver fat and improve signs of ongoing liver injury.

• Metabolic Dysfunction-Associated Steatohepatitis and Non-alcoholic steatohepatitis
• Evaluating whether new treatments can improve liver inflammation and fat accumulation
• Assessing safety and tolerability alongside potential clinical benefit

Research in this field is centered on identifying therapies that may slow or reverse liver disease progression in people affected by metabolic and inflammatory liver conditions.

Several studies at this Spain site are dedicated to eosinophilic esophagitis, a rare chronic condition where immune activity leads to swallowing problems and esophageal inflammation. The trials are comparing new and established treatments to improve both tissue healing and day-to-day symptoms.

• Eosinophilic Esophagitis and eosinophilic esophagitis (EoE)
• Comparing treatment effectiveness for histologic response and symptom improvement
• Supporting better management of a chronic inflammatory digestive disease

These investigations aim to help clinicians find more effective options for patients whose esophageal disease remains active despite current care.

There is also research connected to Cardiovascular Diseases, with a focus on people at risk of heart and blood vessel complications who may receive statin therapy. The main goal is to improve the safety of treatment selection and reduce avoidable side effects.

• Patients at risk of cardiovascular disease receiving statins
• Evaluating a testing strategy to help prevent treatment-related muscle problems
• Supporting safer, more personalized use of lipid-lowering therapy

This line of research highlights how the site contributes not only to digestive and immune disease studies, but also to practical questions about medication safety in common chronic conditions.